Anthropic has launched Claude Science in public beta, and it represents a meaningful shift in how AI tools serve the scientific community. This is not another chatbot wrapper. It is a full research workbench where scientists describe experiments in plain English and Claude executes end-to-end workflows.
Native Integration with NVIDIA BioNeMo
The standout feature is native integration with NVIDIA’s BioNeMo Agent Toolkit. Claude Science connects directly to models like Evo 2, Boltz-2, and OpenFold3 without manual configuration, endpoint setup, or fighting with software environments.
A researcher types a hypothesis in natural language. Claude orchestrates protein structure predictions, molecular simulations, and data analysis across high-performance compute, all automatically.
Pharma Industry Adoption
The timing is significant. Eighteen of the top 20 global pharmaceutical companies already run BioNeMo in production. Now their researchers can access that computational power through conversation rather than through complex engineering pipelines.
Funding Opportunity
Anthropic is funding up to 50 Claude Science projects with $30,000 in credits each. Applications close July 15, 2026. Teams working at the intersection of AI and scientific research should take a close look at this opportunity.
Takeaway
This is where AI gets serious in the sciences. Claude Science is not replacing scientists. It is removing the engineering overhead that slows discovery down, letting researchers focus on hypotheses and analysis rather than infrastructure and configuration.
